Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Summary of Loss Per Share Restated Amounts

See the table presentation of loss per share calculations as of September 30, 2023 and 2022 in the "Loss Per Share" section below.

	Three Months Ended September 30,			Nine Months Ended September 30,
		2022			2022
As Previously Reported:
Net loss per share attributable to common stockholders - basic and diluted		$	(0.40)		$	(1.75)
Weighted average number of shares of common stock outstanding - basic and diluted		10,528,148			9,299,788
As Restated:
Net loss per share attributable to common stockholders - basic and diluted		$	(0.23)		$	(1.26)
Weighted average number of shares of common stock outstanding - basic and diluted		18,463,673			12,902,890

Schedule of Basic and Diluted Net Loss Per Share

Basic and diluted net loss per share for the three and nine months ended September 30, 2023 and 2022, after giving effect to the restatement discussed above, was calculated as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands, Except Share and Per Share Amounts)	2023		2022		2023		2022
Numerator:
Net loss	$	(1,872)	$	(4,190)	$	(6,927)	$	(16,317)
Net loss attributable to common stockholders for basic and diluted loss per share	$	(1,872)	$	(4,190)	$	(6,927)	$	(16,317)
Denominator:
Weighted average number of shares of common stock outstanding - basic and diluted	27,521,088		18,463,673		21,526,978		12,902,890
Net loss per share attributable to common stockholders - basic and diluted	$	(0.07)	$	(0.23)	$	(0.32)	$	(1.26)

Summary of Potentially Dilutive Securities

The following table includes the potential shares of common stock, presented based on amounts outstanding at each period end, that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

	As of September 30,
	2023	2022
Options to Purchase Common Stock	1,367,493	1,311,691
Unvested Restricted Stock Awards	891	891
Unvested Restricted Stock Units	287,400	125,000
Convertible Preferred Stock	1,363,636	1,363,636
Warrants to Purchase Common Stock	4,045,278	17,507,268
Total	7,064,698	20,308,486